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Discussion and Future Directions References
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Hypothesis: RHAMM expression promotes invasive growth, proliferation 
of tumor cells and chemotherapeutic resistance in TNBC
Specific Objectives:
1. Compare the levels of proliferation between RHAMM+/+ and RHAMM -
/- MDA-MB-231 spheroids as determined by ki67 and Caspase 3 
signaling
2. Compare levels of RHAMM, CD44, Has2, and p-ERK activation between 
RHAMM+/+ and RHAMM -/- MDA-MB-231 spheroids
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Figure 1. Activation of CD44, Erk, and Tumor 
Invasion and Proliferation via RHAMM-
Dependent Pathway7
3London Regional Cancer Program, London, Ontario, Canada, N6A 4L6
Breast cancer manifests heterogeneously in both clinical and molecular contexts, accounting 
for 25% of new cancer cases for women in Canada. While improvements in multi-modal 
therapy and population screening programs have increased survival dramatically1, breast 
cancer remains as the second leading cause of cancer mortality in women in North America 
due to its high overall incidence.
In particular, Triple Negative Breast Cancer (TNBC) is particularly threatening due to rapid local 
invasive growth, metastasis, and chemotherapeutic resistance. While PARP and immune 
checkpoint inhibitors have proven useful for treating specific subsets of TNBC, effective 
therapies are still lacking for the majority of these patients2. 
The Turley and collaborator’s laboratories (MJ Bissell, LBNL; JB McCarthy, UMN; and A Nelson, 
UMN) have shown that high expression of an HA receptor,
Figure 1. The loss of RHAMM reduces proliferation and cell signaling in MDA-MB-231 spheroids. MDA-MB-231 3D spheroids were grown for seven days and 
processed into paraffin-embedded sections. Representative images of RHAMM+/+ and RHAMM-/- MDA-MB-231 spheroid sections stained with (A) CD44 (red), 
(C) HAS2 (red), (E) RHAMM (red), (G) p-ERK (green), (I) Cleaved Caspase 3 (green) and (K) ) Ki67 (red) antibodies and counter-stained with DAPI (blue). 
Fluorescence quantification of (B) CD44, (D) HAS2, (F) RHAMM, (H) p-ERK, (J) Cleaved Caspase 3 and (L) Ki67 expression measured in ImageJ. Significant 
values are p<0.01 (**) and p<0.0001 (****) as determined by unpaired student’s t-tests. Data represent mean ± SD.
Discussion:
• As the presence of HA elevates CD44 expression, CD44 would be expected to be more highly expressed in RHAMM+/+ 
MDA-MB-231
• Caspase 3 may be more highly expressed in RHAMM+/+ MDA-MB-231 due to HA-mediated promotion of apoptosis
• RHAMM is required for translocation of p-ERK, so p-ERK expression is expected to increase in RHAMM+/+ MDA-MB-
2315,6
• Since Has2 has hyaluronan-mediated interactions with RHAMM, RHAMM expression could thus trigger Has2 
expression
Future Direction:
• Quantification via qT-PCR/RT-PCR of markers presented could affirm findings presented
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HMMR (aka RHAMM) is linked 
to poor outcome in TNBC cell 
subsets and is a critical factor in 
the experimental progression 
and metastasis of TNBC. 
Previous studies suggest that 
RHAMM drives TNBC 
progression through an 
association with HA, the HA 
receptor CD44 and pro-
migration/invasion signaling 
regulated by ERK1,23,4. TNBC 
cell lines lacking RHAMM 
expression via CRISPR-Cas9 
gene editing are poorly invasive 
and metastatic in both 
orthotopic and lung 
colonization assays. 
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